CURE vs. RBIL
CURE (Direxion Daily Healthcare Bull 3x Shares) and RBIL (F/m Ultrashort Treasury Inflation-Protected Security (TIPS) ETF) are both exchange-traded funds - CURE is a Leveraged Equities fund tracking the Health Care Select Sector Index (300%), while RBIL is a Inflation-Protected Bonds fund tracking the Bloomberg US Ultrashort TIPS 1-13 Months Index. Both are passively managed. Over the past year, CURE returned 30.81% vs 3.95% for RBIL. At a correlation of -0.14, they often move in opposite directions. CURE charges 1.08%/yr vs 0.17%/yr for RBIL.
Performance
CURE vs. RBIL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CURE achieves a -13.71% return, which is significantly lower than RBIL's 2.31% return.
CURE
- 1D
- 2.67%
- 1M
- 0.35%
- YTD
- -13.71%
- 6M
- -14.70%
- 1Y
- 30.81%
- 3Y*
- 0.21%
- 5Y*
- 0.03%
- 10Y*
- 13.61%
RBIL
- 1D
- -0.05%
- 1M
- -0.20%
- YTD
- 2.31%
- 6M
- 2.35%
- 1Y
- 3.95%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CURE vs. RBIL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | -13.71% | 1.77% |
RBIL F/m Ultrashort Treasury Inflation-Protected Security (TIPS) ETF | 2.31% | 2.85% |
Correlation
The correlation between CURE and RBIL is -0.17, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.17 |
Correlation (All Time) Calculated using the full available price history since Feb 25, 2025 | -0.14 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CURE vs. RBIL — Risk / Return Rank
CURE
RBIL
CURE vs. RBIL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and F/m Ultrashort Treasury Inflation-Protected Security (TIPS) ETF (RBIL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CURE | RBIL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.48 | ||
| Sortino ratioReturn per unit of downside risk | -5.08 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 2.06 | -0.92 |
| Calmar ratioReturn relative to maximum drawdown | 1.00 | 7.59 | -6.59 |
| Martin ratioReturn relative to average drawdown | 2.22 | 44.07 | -41.86 |
Loading charts...
Drawdowns
CURE vs. RBIL - Drawdown Comparison
The maximum CURE drawdown since its inception was -69.19%, which is greater than RBIL's maximum drawdown of -0.52%. Use the drawdown chart below to compare losses from any high point for CURE and RBIL.
Loading charts...
Drawdown Indicators
| CURE | RBIL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.19% | -0.52% | -68.67% |
Max Drawdown (1Y)Largest decline over 1 year | -31.10% | -0.52% | -30.58% |
Max Drawdown (3Y)Largest decline over 3 years | -51.93% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -52.23% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -69.19% | — | — |
Current DrawdownCurrent decline from peak | -31.51% | -0.51% | -31.00% |
Average DrawdownAverage peak-to-trough decline | -18.18% | -0.07% | -18.11% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.94% | 0.09% | +13.85% |
Volatility
CURE vs. RBIL - Volatility Comparison
Direxion Daily Healthcare Bull 3x Shares (CURE) has a higher volatility of 15.11% compared to F/m Ultrashort Treasury Inflation-Protected Security (TIPS) ETF (RBIL) at 0.36%. This indicates that CURE's price experiences larger fluctuations and is considered to be riskier than RBIL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CURE | RBIL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.11% | 0.36% | +14.75% |
Volatility (6M)Calculated over the trailing 6-month period | 30.86% | 0.85% | +30.01% |
Volatility (1Y)Calculated over the trailing 1-year period | 44.43% | 0.95% | +43.48% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.89% | 1.07% | +42.82% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.63% | 1.07% | +48.56% |
CURE vs. RBIL - Expense Ratio Comparison
CURE has a 1.08% expense ratio, which is higher than RBIL's 0.17% expense ratio.
Dividends
CURE vs. RBIL - Dividend Comparison
CURE's dividend yield for the trailing twelve months is around 1.24%, less than RBIL's 4.38% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 1.24% | 1.12% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% |
RBIL F/m Ultrashort Treasury Inflation-Protected Security (TIPS) ETF | 4.38% | 3.65% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
CURE and RBIL have a correlation of -0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CURE has higher volatility (15.11%) compared to RBIL (0.36%). In terms of maximum drawdown, CURE dropped -69.19% vs RBIL's -0.52%.
On 1-year performance, CURE leads with 30.81% vs 3.95% for RBIL. On fees, RBIL is cheaper at 0.17% per year. On volatility, RBIL has been the lower-risk option at 0.36%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, CURE has performed better with a 30.81% return vs 3.95%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
RBIL is cheaper with a 0.17% expense ratio, compared with 1.08% for CURE.
RBIL has the higher dividend yield at 4.38%, compared with 1.24% for CURE.
CURE is categorized as Leveraged Equities, while RBIL is Inflation-Protected Bonds. CURE tracks Health Care Select Sector Index (300%), while RBIL tracks Bloomberg US Ultrashort TIPS 1-13 Months Index. They also come from different issuers: Direxion and F/m. Their fees differ too: 1.08% for CURE and 0.17% for RBIL.
RBIL currently has the higher Sharpe Ratio (4.18 vs 0.70), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CURE and RBIL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer